45

HASS Corp

450330 · KQ · Healthcare / Medical Instruments & Supplies

3,935.00KRW-15.00 (-0.38%)

Price History

Full chart

Market Stats

Previous Close3,950.00
Open3,980.00
Day Range3,920.00 – 4,080.00
52-Week Range3,650.00 – 8,700.00
Volume4.76K
Market Cap38.61B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield1.20%
Beta0.30
50-Day Avg4,824.60
200-Day Avg5,824.03

About

Hass Corp. manufactures and sells dental medical devices. Its CAD/CAM systems include Amber Mill, a machinable dental glass-ceramic blocks made of lithium disilicate; Amber Mill Direct, a CAD/CAM-based millable lithium disilicate block; Amber Mill H, a CAD/CAM block using nano-crystalline ceramics particle; Amber Mill Q, an implant abutment solution; and Amber Mill Meso, a lithium disilicate-based block for implant prosthese. The company's heat-pressing systems comprise Amber Press, a lithium disilicate-based press ingots; Amber Press Master, a lithium disilicate-based high fusion press ingots; and Amber LiSi-POZ and Amber LiSi-POM for lithium disilicate-based press on zirconia. In addition, it offers Amber Vest, an ultra-fine phosphate bound investment for pressable dental ceramics; COCO Lux, a mobile dental photography solution; Selection Tip, a shade matching solution; and Amber Glow, a polish for zirconia, lithium disilicate, porcenlain, and composite. The company was founded in 2008 and is headquartered in Gangneung-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • Employees106
  • Headquarters77-14, Gwahakdanji-ro, Gangneung-si, South Korea, 25452, Korea
  • Websitehttps://www.hassbio.com

Financials

Income Statement

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue12.60B14.91B16.04B16.16B16.59B
Growth (%)-+18.37%+7.57%+0.78%+2.64%
Cost of Revenue5.59B5.99B7.22B7.45B7.64B
Gross Profit7.01B8.92B8.82B8.72B8.95B
Gross Margin55.63%59.82%54.98%53.92%53.93%
Operating Expense5.27B6.03B7.20B7.48B8.04B
Operating Income1.73B2.89B1.61B1.24B902.81M
Operating Margin13.76%19.41%10.06%7.66%5.44%
EBITDA-4.05B2.96B3.39B3.30B
EBITDA Margin-27.15%18.43%20.96%19.91%
Net Income1.56B2.64B1.80B1.79B1.55B
Net Income Margin12.37%17.73%11.20%11.08%9.33%
R&D1.08B1.04B933.57M1.29B1.25B
R&D as % of Total Revenue8.61%7.00%5.82%7.97%7.55%
Interest Expense73.15M185.53M294.48M250.00M138.51M
Interest Expense % of Total Revenue0.58%1.24%1.84%1.55%0.83%

Balance Sheet

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets16.40B18.94B29.18B54.88B54.85B
Total Liabilities8.69B7.99B14.03B9.43B8.47B
Total Equity7.71B10.96B15.15B45.46B46.38B
Cash1.28B659.09M2.41B2.84B7.07B
Net Debt4.25B4.92B9.38B4.41B-

Cash Flow

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.78B3.41B1.50B1.15B1.82B
Investing Cash Flow--3.97B-7.34B-24.35B-
Financing Cash Flow--84.60M7.62B23.62B-
Capital Expenditure3.13B4.86B8.40B3.64B2.23B
Free Cash Flow-1.35B-1.45B-6.91B-2.50B-409.29M
Dividends Paid----548.52M
FCF to OCF-76.08%-42.42%-461.22%-217.41%-22.50%
Dividend Paid to FCF-----134.02%

Earnings

Report DateSep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------
EPS Actual-9.51130.77-97.15119.0037.62121.14-115.05-74.86
Surprise--------
Timing--------

Key Statistics & Ratios

Market Cap38.61B
Enterprise Value30.21B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.40
Price / Book0.91
Revenue (TTM)16.08B
Gross Profit (TTM)8.29B
EBITDA1.10B
Profit Margin-0.97%
Operating Margin-14.94%
Return on Equity-0.36%
Return on Assets-0.95%
Shares Outstanding7.75M
Shares Float2.96M
Beta0.30
Dividend Yield1.20%
Dividend Rate60.00
Payout Ratio34.48%

Dividends

20261×
60.00Mar 18, 2026
20241×
70.00Dec 27, 2024